Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion
AbstractIntroduction Artificial intelligence (AI) is expected to impact all facets of inflammatory bowel disease (IBD) management, including disease assessment, treatment decisions, discovery and development of new biomarkers and therapeutics, as well as clinician–patient communication.Areas covered...
Main Author: | Philippe Pinton |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2023.2300670 |
Similar Items
-
Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2020-06-01) -
Faecal calprotectin – a useful tool in the management of inflammatory bowel disease
by: Emanuel Burri, et al.
Published: (2012-03-01) -
Methanogenic Archaea in the Pediatric Inflammatory Bowel Disease in Relation to Disease Type and Activity
by: Agata Anna Cisek, et al.
Published: (2024-01-01) -
An Improved Score for the Evaluation of Mucosal Healing in Inflammatory Bowel Disease—A Pilot Study
by: Lidia Neamți, et al.
Published: (2023-02-01) -
Fecal Calprotectin, Chitinase 3-Like-1, S100A12 and Osteoprotegerin as Markers of Disease Activity in Children with Crohn’s Disease
by: Adriaan G. Volkers, et al.
Published: (2022-08-01)